Enoximone echocardiography for predicting recovery of left ventricular dysfunction after revascularization - A novel test for detecting myocardial viability
Cz. Lu et al., Enoximone echocardiography for predicting recovery of left ventricular dysfunction after revascularization - A novel test for detecting myocardial viability, CIRCULATION, 101(11), 2000, pp. 1255-1260
Citations number
33
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-The possibility that enoximone, a nonglycoside, noncatechol, pos
itive inotropic agent, in combination with 2-dimensional echocardiography m
ay predict recovery of myocardial dysfunction after revascularization has n
ot been yet evaluated.
Methods and Results-Forty-five patients with chronic coronary artery diseas
e and left ventricular dysfunction underwent dobutamine (DE, 5 to 10 mu g .
kg(-1) . min(-1)) and enoximone (EE, 1.5 mg/kg, over 10 minutes) echocardi
ography. Myocardial wall motion was scored from 1 (normal) to 4 (dyskinesia
): an asynergic segment was considered to have contractile enhancement when
the score decreased by greater than or equal to 1 grade. Of 478 asynergic
segments, 216 (45%) exhibited functional recovery after revascularization.
Dobutamine- and enoximone-induced contractile enhancement was observed in 4
1% and 46% of segments, respectively, Compared with DE, EE had higher sensi
tivity (88% versus 79%, P<0.01) and negative predictive value (90% versus 8
4%, P<0.05) in predicting functional recovery. The specificity (89% versus
90%) and positive predictive value (87% for both EE and DE) were similar. C
oncordant interpretation of EE and DE findings was found in 85% (406 of 478
) of affected segments. Prerevascularization coronary angiography showed th
at stenosis severity of vessels supplying areas which only improved with en
oximone was significantly greater (89.9%) than that of vessels (77.7%) supp
lying areas that responded to both agents (P<0.02), Both dobutamine and eno
ximone increased heart rate (16% and 10%, respectively), whereas enoximone
did not cause changes in systolic blood pressure that increased by 14% with
dobutamine.
Conclusions-Enoximone echocardiography provides a novel and reliable approa
ch for the prediction of functional recovery after revascularization. Compa
red with dobutamine echocardiography, the test yields higher sensitivity an
d induces lesser hemodynamic alterations.